{"id":"procaine-penicillin-gentamicin-amoxicillin","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"1-5%","effect":"Allergic reactions"},{"rate":"1-5%","effect":"Neurotoxicity"}]},"_chembl":{"chemblId":"CHEMBL1200936","moleculeType":"Small molecule","molecularWeight":"588.73"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Procaine penicillin, gentamicin, and amoxicillin are all bactericidal agents that target different aspects of bacterial physiology. Procaine penicillin and amoxicillin inhibit cell wall synthesis by binding to penicillin-binding proteins, while gentamicin inhibits protein synthesis by binding to the 30S ribosomal subunit. This combination of antibiotics is used to treat a variety of bacterial infections.","oneSentence":"Procaine penicillin is a combination antibiotic that works by inhibiting bacterial cell wall synthesis and protein synthesis, while gentamicin is an aminoglycoside antibiotic that works by inhibiting protein synthesis, and amoxicillin is a beta-lactam antibiotic that works by inhibiting cell wall synthesis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:30:13.754Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of bacterial infections, including pneumonia, meningitis, and septicemia"}]},"trialDetails":[{"nctId":"NCT02701595","phase":"PHASE3","title":"Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2016-02-29","conditions":"Infective Endocarditis","enrollment":324},{"nctId":"NCT05929599","phase":"NA","title":"Efficacy of LiveSpo Navax in Supportive Treatment of Pneumonia in Children With RSV and Bacterial Co-infections","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Children's Hospital, Vietnam","startDate":"2023-07-05","conditions":"Acute Respiratory Tract Infections, Pneumonia, Respiratory Syncytial Virus (RSV)","enrollment":120},{"nctId":"NCT04041791","phase":"PHASE3","title":"A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2019-08-19","conditions":"Pneumonia","enrollment":4392},{"nctId":"NCT02848820","phase":"PHASE4","title":"Initial Non-operative Treatment Strategy Versus Appendectomy Treatment Strategy for Simple Appendicitis in Children","status":"UNKNOWN","sponsor":"Ramon Gorter","startDate":"2016-12","conditions":"Appendicitis","enrollment":302},{"nctId":"NCT05106803","phase":"","title":"Antibiotic Profile of Pathogenic Bacteria Isolated in Public Hospitals in Northern Jordan","status":"COMPLETED","sponsor":"Yarmouk University","startDate":"2019-08-01","conditions":"Bacterial Infections, Antibiotic Resistant Infection, Surgical Site Infection","enrollment":24},{"nctId":"NCT03369093","phase":"NA","title":"RCT of Efficacy of Amoxicillin Over Ampicillin on Severe Pneumonia","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2018-01-01","conditions":"Treatment Failure, Lethargy, Altered Mental Status","enrollment":308},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT02960919","phase":"","title":"Innovative Treatments in Pneumonia (ITIP) 3","status":"COMPLETED","sponsor":"Save the Children","startDate":"2016-10-19","conditions":"Pneumonia","enrollment":1001},{"nctId":"NCT02018094","phase":"PHASE4","title":"The Amputation Surgical Site Infection Trial (ASSIT)","status":"COMPLETED","sponsor":"Hull University Teaching Hospitals NHS Trust","startDate":"2013-10-08","conditions":"Wound Infection, Amputation Wound","enrollment":160},{"nctId":"NCT01027429","phase":"PHASE3","title":"Simplified Antibiotic Therapy for Sepsis in Young Infants","status":"COMPLETED","sponsor":"Aga Khan University","startDate":"2009-12","conditions":"Neonatal Sepsis, Sepsis, Infection","enrollment":2543},{"nctId":"NCT01333982","phase":"NA","title":"Neonatal Sepsis, Evaluation, Bangladesh","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2010-04","conditions":"Sepsis","enrollment":20000},{"nctId":"NCT00844337","phase":"NA","title":"Simplified Antibiotic Regimens for Outpatient Treatment of Suspected Sepsis in Neonates and Young Infants in Bangladesh","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2009-03","conditions":"Sepsis","enrollment":2490},{"nctId":"NCT01559753","phase":"PHASE4","title":"Early-onset Ventilator-associated Pneumonia in Adults: Comparison of 8 Versus 15 Days of Antibiotic Treatment","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"1998-01","conditions":"Pneumonia Ventilator Associated","enrollment":225}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"procaine penicillin, gentamicin, amoxicillin","genericName":"procaine penicillin, gentamicin, amoxicillin","companyName":"Aga Khan University","companyId":"aga-khan-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Procaine penicillin is a combination antibiotic that works by inhibiting bacterial cell wall synthesis and protein synthesis, while gentamicin is an aminoglycoside antibiotic that works by inhibiting protein synthesis, and amoxicillin is a beta-lactam antibiotic that works by inhibiting cell wall synthesis. Used for Treatment of bacterial infections, including pneumonia, meningitis, and septicemia.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}